Education

Graduate School
Boston University School of Medicine (2009)
Medical School
Drexel University College of Medicine (2013)
Residency
Tufts Medical Center (2016), Internal Medicine
Fellowship
Montefiore Medical Center (2019), Hematology Oncology

Publications

Featured Publications LegendFeatured Publications

Treatment of Smoldering Myeloma: Problems With Study Design as well as Biological and Clinical Implications.
Biran N, Vesole DH, Donato ML, Ip A, Kaur G, Goldberg S, Siegel DS, J Clin Oncol 2020 Apr 38 12 1367-1368
Multiple myeloma in Hispanics- incidence, characteristics and survival, results of a discovery & validation cohort using real world and CONNECT data
Kaur et al Clinical Lymphoma, Myeloma and Leukemia 2020
Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies.
Wang H, Kaur G, Sankin AI, Chen F, Guan F, Zang X, J Hematol Oncol 2019 06 12 1 59
B7x- From Bench to Bedside
Kaur G, Janakiram M ESMO Open 2019
Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.
Mato AR, Nabhan C, Barr PM, Ujjani CS, Hill BT, Lamanna N, Skarbnik AP, Howlett C, Pu JJ, Sehgal AR, Strelec LE, Vandegrift A, Fitzpatrick DM, Zent CS, Feldman T, Goy A, Claxton DF, Bachow SH, Kaur G, Svoboda J, Nasta SD, Porter D, Landsburg DJ, Schuster SJ, Cheson BD, Kiselev P, Evens AM, Blood 2016 11 128 18 2199-2205
Translational research in pancreatic adenocarcinoma.
Kaur G, Saif MW, JOP 2014 Mar 15 2 121-3